CSIMarket



Imara inc.  (IMRA)
Other Ticker:  
 
 

IMRA's Net Income Growth by Quarter and Year

Imara's Net Income results by quarter and year




IMRA Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -6.42 -11.52 0.00
III Quarter September - -13.65 -12.42 0.00
II Quarter June -11.45 -13.16 -10.20 0.00
I Quarter March -14.64 -10.26 0.64 0.00
FY   -26.09 -43.49 -33.50 -



IMRA Net Income second quarter 2022 Y/Y Growth Comment
Imara inc. in the second quarter 2022 recorded net loss of $ -11.45 millions.

According to the results reported in the second quarter 2022, Imara Inc. achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Imara Inc.' s Net Income no change of % ranks overall at the positon no. in the second quarter 2022.




IMRA Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Imara's second quarter 2022 Net Income $ -11.45 millions IMRA's Income Statement
Imara's second quarter 2021 Net Income $ -13.16 millions Quarterly IMRA's Income Statement
New: More IMRA's historic Net Income Growth >>


IMRA Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Imara's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMRA's II. Quarter Q/Q Net Income Comment
Despite the fact, that Imara inc. in the II. Quarter 2022 revealed net loss of $ -11.45 millions, management said, that this show slight up side compare to the -14.64 millions in the first quarter.

Within Major Pharmaceutical Preparations industry Imara inc. achieved highest sequential Net Income growth. While Imara's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMRA's II. Quarter Q/Q Net Income Comment
Even if Imara inc. in the II. Quarter 2022 showed net loss of $ -11.45 millions, some analyst point out, that current results show improvement in contrast to the -14.64 millions in the first quarter.

Within Major Pharmaceutical Preparations industry Imara inc. achieved highest sequential Net Income growth. While Imara's Net Income growth quarter on quarter, overall rank is .


Imara's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
Cumulative Net Income 12 Months Ending $ -46.15 $ -47.87 $ -43.48 $ -48.58 $ -47.36
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment


Imara inc. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Imara inc. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
IMRA's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for IMRA's Competitors
Net Income Growth for Imara's Suppliers
Net Income Growth for IMRA's Customers

You may also want to know
IMRA's Annual Growth Rates IMRA's Profitability Ratios IMRA's Asset Turnover Ratio IMRA's Dividend Growth
IMRA's Roe IMRA's Valuation Ratios IMRA's Financial Strength Ratios IMRA's Dividend Payout Ratio
IMRA's Roa IMRA's Inventory Turnover Ratio IMRA's Growth Rates IMRA's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Jun 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2022
Resmed Inc.-0.02%$ -0.020 millions
Hanger inc.-0.41%$ -0.413 millions
Addus Homecare Corporation-2.99%$ -2.992 millions
Electromed Inc.-4.14%$ -4.140 millions
Prestige Consumer Healthcare Inc.-5.93%$ -5.932 millions
National Research Corporation-6.95%$ -6.954 millions
U S Physical Therapy Inc-12.68%$ -12.683 millions
Hologic Inc-14.90%$ -14.903 millions
Baxter International Inc.-15.28%$ -15.282 millions
Bruker Corporation-15.33%$ -15.332 millions
Edwards Lifesciences Corporation-16.98%$ -16.977 millions
Hca Healthcare Inc.-17.13%$ -17.127 millions
Davita Inc.-18.92%$ -18.920 millions
Dexcom Inc.-19.08%$ -19.078 millions
Moderna Inc.-20.97%$ -20.971 millions
Pediatrix Medical Group Inc.-22.48%$ -22.480 millions
Laboratory Corporation Of America Holdings-23.31%$ -23.312 millions
Gilead Sciences Inc.-25.18%$ -25.181 millions
Sotera Health Company-28.62%$ -28.621 millions
Healthcare Services Group Inc.-28.70%$ -28.698 millions
Tenet Healthcare Corp-30.35%$ -30.350 millions
Becton Dickinson And Company-31.24%$ -31.238 millions
Eli Lilly And Company-31.48%$ -31.485 millions
United Therapeutics Corporation-32.79%$ -32.793 millions
La Jolla Pharmaceutical Company-34.15%$ -34.155 millions
Idexx Laboratories Inc-34.86%$ -34.859 millions
Reynolds Consumer Products Inc.-35.00%$ -35.000 millions
Petmed Express Inc.-37.33%$ -37.331 millions
Viemed Healthcare Inc.-38.25%$ -38.250 millions
Royalty Pharma Plc-39.06%$ -39.065 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MARZ's Profile

Stock Price

MARZ's Financials

Business Description

Fundamentals

Charts & Quotes

MARZ's News

Suppliers

MARZ's Competitors

Customers & Markets

Economic Indicators

MARZ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071